The Weekly Litigation News Digest is now live. Subscribe now

IP Verse

Ipsen Biopharma competitive analysis

Loading summary...

Latest oppositions filed by Ipsen Biopharma

Explore patent oppositions filed by Ipsen Biopharma against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Nov 13, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

EP4161562
High Dose And Low Volume Botulinum Toxin Treatment Of Facial WrinklesMERZ PHARMAAug 20, 2025
EP3368071
Injectable Botulinum Toxin Formulations And Methods Of Use Thereof Having Long Duration Of Therapeutic Or Cosmetic EffectREVANCE THERAPEUTICSOct 26, 2022

Latest PTAB cases involving Ipsen Biopharma

Discover the latest PTAB cases involving Ipsen Biopharma, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Ipsen Biopharma with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Nov 13, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
IPSEN BIOPHARMA2 - - -
MERZ PHARMA176 - -
REVANCE THERAPEUTICS - 32 -